Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
May, 21 2026
Apr, 21 2025
Feb, 1 2026
Jan, 24 2026
Aug, 28 2026